Follow Us:Respiratio 2018; 8 (1-2): 7-13
IMPORTANCE OF ELECTROCARDIOGRAPHIC EVALUATIONIN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Daniela Buklioska Ilievska¹, Nade Kochovska Kamchevska¹
¹City General Hospital, Skopje, FJR Macedonia
Original research
Naučni članak
doi: 10.26601/rsp.aprs.18.2
Summary: Introduction: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in the world and fourth leading cause after myocardial infarction, malignant diseases and cerebrovascular incidents. Patients with COPD are at increased risk of cardiovascular disease. Electrocardiography (ECG) carries valuable information about cardiac disease and prognosis.
Aim: To evaluate major ECG changes and their corelation to COPD severity.
Material and methods: Cross sectional study was conducted at 120 patients with COPD (age 40-75) and 60 subjects from general population without COPD, matched by age, gender and body mass index. All patients underwent resting ECG, 24 hour-ECG-Holter monitoring and pulmonary function tests.
Results: Abnormal ECG is more prevalent in COPD (83,33%) than in controls (26,67%). ECG findings in COPD: atrial fibrillation (AFF) (13,33%), tachycardia (36,67%), right axis deviation (23,33%), p-pulmonale (41,67%), right bundle branch block (15%), premature supraventricular (PSCs) and ventricular (PVCs) contractions (15%). ECG abnormalities due to right ventricular hypertrophy are increasing with COPD severity. Mean oxygen saturation in patients with tachycardia is lower than in those without (79,5%<92,9%). 24-hour-ECG-Holter monitoring allows detection of arrhythmias in asymptomatic patients and detected abnormalities were significantly higher compared to resting 12-lead-ECG. 24-hour-ECG-Holter results: PSCs (56,67%), paroxysmal supraventricular tachycardia (20%), PVCs (41,66%), PVC bigeminy (15%), ventricular couplets (10%), un-sustained ventricular tachycardia (5%), atrio-ventricular block of first degree (1,67%).
Conclusion: The prevalence of ECG abnormalities increases with COPD severity. Integrated-care approach for COPD patients is important for early detection of unrecognized coexisting cardiac disorders.
Keywords: COPD, ECG, right axis deviation, p pulmonale.
REFERENCES
|
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Executive Summary: Global Strategy for Diagnosis, Management, and Prevention of COPD - Updated 2018. |
|
|
|
|
|
2. Marie M. Budev, DO, MPH, Alejandro C. Arroliga, MD, Herbert P. Wiedemann, MD, and Richard A. Matthay, MD. Cor Pulmonale: An Overview. Semin Respir Crit Care Med. 2003;24(3):233-44. |
|
|
|
|
|
3. Anthony S. Fauci A, Braunwald E, et al. Principles of Harrison's Internal Medicine. 17th Ed. New York: McGraw-Hill, 2008; pp. 1635-1642. |
|
|
|
|
|
4. Don DS, Man P. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular diseasel. Can J Physiol Pharmacol 2005;83(1):8-13. |
|
|
|
|
|
5. Sabit R, Bolton C, et al. Sub-clinical left and right ventricular dysfunction in patients with COPD. Respiratory medicine. 2010; 104(8):1171-1178. |
|
|
|
|
|
6. Lucas-Ramos P, Izquierdo-Alonso J, Rodriguez-Gonzalez J, Fernandez Frances J, Lozano P, Bellón-Cano J. Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case–control study (CONSISTE study). International Journal of COPD. 2012;7 679–686. |
|
|
|
|
|
7. Jeremy A, Kadiev S, Criner G, Scharf S, Minai O, Diaz P. Cardiac disease in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2008; 5(4):543-548. |
|
|
|
|
|
8. Hunninghake D. Cardiovascular Disease in Chronic Obstructive Pulmonary Disease. Proc Am Thorac. Soc. 2005; 2:44-49. |
|
|
|
|
|
9. Finkelstein J, Cha E, Scharf S. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. International Journal of COPD. 2009; 4:337 – 349. |
|
|
|
|
|
10. Harrigan RA, Jones K. ABC of clinical electrocardiography. Conditions affecting the right side of heart. BMJ.2002;324:1201-1204. |
|
|
|
|
|
11. Cardiac arrhythmia in patients with chronic obstructive pulmonary diseases. DocGuide.com. Pulmonology.2005 |
|
|
|
|
|
12. Criner GJ. COPD and the heart: when less lung means more heart. Chest 2010; 138(1):6–8. |
|
|
|
|
|
13. Jeremy A, Kadiev S, Criner G, Scharf S, Minai O, Diaz P. Cardiac disease in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc. 2008; 5(4):543-548. |
|
|
|
|
|
14. Hunninghake D. Cardiovascular Disease in Chronic Obstructive Pulmonary Disease. Proc Am Thorac. Soc. 2005; 2:44-49. |
|
|
|
|
|
15. Finkelstein J, Cha E, Scharf S. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. International Journal of COPD. 2009; 4:337 – 349. |
|
|
|
|
|
16. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003;21(6):1012-6. |
|
|
|
|
|
17. Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, Igarashi A, Yamauchi K, Kimura T, Kishi H, Aida Y, Nunomiya K, Nemoto T, Sato M, Konta T, Kawata S, Kato T, Kayama T, Kubota I. Impairment of Pulmonary Function is an Independent Risk Factor for Atrial Fibrillation: The Takahata Study. Int J Med Sci. 2011; 8(7):514-522. |
|
|
|
|
|
18. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: A meta-analysis. Chest 2004; 125(6):2309–2321. |
|
|
|
|
|
19. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH Investigators. Salmeterol amd fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789. |
|
|
|
|
|
20. Warnier MJ, Rutten FH, Numans ME, Kors JA, Tan HL, de Boer A, Hoes AW, De Bruin ML. Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease. COPD. 2013 Feb;10(1):62-71. |
|
|
|
|
|
21. Holtzman D, Aronow WS, Mellana WM, Sharma M, Mehta N, Lim J, et al. Electrocardiographic abnormalities in patients with severe versus mild or moderate chronic obstructive pulmonary disease followed in an academic outpatient pulmonary clinic. Ann Noninvas Electrocardiol 2011; 16(1):30–32. |
|
|
|
|
|
22. Gunduz H, Talay F, Arinc H, Ozyildirim S, Akdemir R, Yolcu M, et al. Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol J 2009; 16(6):553–559. |
|
|
|
|
|
23. Volterrani M, Scalvini S, Mazzuero G, Lanfranchi P, Colombo R, Clark AL, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106(5):1432–1437. |
|
|
|
|
|
24. Dabadghao VS et al. A clinical study of cardiac rhythm disturbance in patients with chronic obstructive pulmonary disease using 24 hour Holter monitoring. International Journal of Research in Medical Sciences (Int J Res Med Sci). 2016 Mar;4(3):701-705.
Daniela Buklioska Ilievska Adress: ,,Nikola Parapunov” 31/1-3 Skopje, Macedonia Tel: 00389 70304066 e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it. |
|